Dyne Therapeutics, Inc.
DYN
$25.70
-$0.26-1.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 898.48M | 972.16M | 1.11B | 791.89M | 683.93M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 39.41M | 48.87M | 16.03M | 14.38M | 14.03M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 937.89M | 1.02B | 1.13B | 806.26M | 697.95M |
|
|
|||||
| Total Current Assets | 937.89M | 1.02B | 1.13B | 806.26M | 697.95M |
| Net Property, Plant & Equipment | 44.82M | 43.33M | 44.77M | 45.79M | 28.53M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.31M | 15.59M | 15.60M | 15.01M | 2.51M |
| Total Assets | 994.01M | 1.08B | 1.19B | 867.06M | 728.99M |
|
|
|||||
| Total Accounts Payable | 12.15M | 10.78M | 8.08M | 12.06M | 14.02M |
| Total Accrued Expenses | 46.36M | 29.21M | 37.55M | 42.75M | 22.45M |
| Short-term Debt | 14.15M | 6.22M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.37M | 5.03M | 5.00M | 5.04M | 5.00M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 78.03M | 51.25M | 50.63M | 59.85M | 41.47M |
|
|
|||||
| Total Current Liabilities | 78.03M | 51.25M | 50.63M | 59.85M | 41.47M |
| Long-Term Debt | 199.33M | 149.38M | 148.92M | 99.15M | 98.81M |
| Short-term Debt | 14.15M | 6.22M | -- | -- | -- |
| Capital Leases | 14.51M | 14.27M | 15.28M | 16.28M | 17.26M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 291.86M | 214.90M | 214.83M | 175.28M | 157.55M |
|
|
|||||
| Common Stock & APIC | 2.40B | 2.38B | 2.37B | 1.98B | 1.75B |
| Retained Earnings | -1.70B | -1.52B | -1.40B | -1.28B | -1.18B |
| Treasury Stock & Other | -353.00K | -137.00K | 475.00K | 496.00K | 252.00K |
| Total Common Equity | 702.15M | 865.06M | 972.13M | 691.78M | 571.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 702.15M | 865.06M | 972.13M | 691.78M | 571.45M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 702.15M | 865.06M | 972.13M | 691.78M | 571.45M |
|
|
|||||